Impaired redistribution of ATM-phosphorylated Nbs1 in Mdc1-depleted cells. (A, B) U-2-OS cells were treated with control (A) and Mdc1-specific (B) siRNA oligonucleotides for 96 h, microirradiated, incubated for 10 min, fixed, and co-immunostained with phospho-specific antibodies to γ-H2AX and Nbs1(S343). (C) U-2-OS cells were transfected with control or Mdc1-specific siRNA duplexes for 96 h and exposed to IR (2 Gy). At the indicated time points, the cell lysates were analysed by immunoblotting with the phospho-specific antibody to Nbs1(S343). (D) U-2-OS cells were treated with Mdc1-specific siRNA oligonucleotides for 72 h, microinjected with the Nbs1-H2B-GFP expression plasmid (10 μg/ml), incubated for additional 36 h, pre-extracted to remove the bulk of endogenous Nbs1 (Materials and methods), fixed, and immunostained with the indicated antibodies. Note the stronger, DSB-restricted Nbs1-S343 phosphorylation in the cell nucleus expressing the immobile form of Nbs1 (marked by solid circle) compared to the neighbouring control nucleus (dashed circle). The insets show enlargements of the respective segments in the merged image. (E, F) U-2-OS cells were treated with control (E) or Mdc1-targeting (F) siRNA oligonucleotides, and microirradiated as in (A, B). After 10 min, the cells were pre-extracted for 5 min (Materials and methods), fixed, and co-immunostained with the indicated phospho-specific antibodies. The insets show magnified microirradiated fields. The arrows indicate the laser movement during microirradiation. Scale bars=10 μm.